Skip to Main Content

Paper Details

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Stroke
29
2021
Author NameAffiliation
Patrick YuePortola Pharmaceuticals, now Alexion Pharmaceuticals
Joshua N GoldsteinMassachusetts General Hospital
  • 1 - 2

Datasets

Release 1.2